Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

Medigene AG. (3/28/17). "Press Release: Medigene Announces Participation at Six National and International Conferences". Planegg.

Organisations Organisation Medigene AG (MDG1, Frankfurt, Prime Standard)
  Group Medigene (Group)
  Organisation 2 Oslo University Hospital
  Group University of Oslo
Products Product Needham & Company 16th Annual Healthcare Conference 2017 New York
  Product 2 BioCentury Annual Future Leaders in the Biotech Industry Conference 2017 New York
Index terms Index term Medigene–Needham: investor conference, 201704 supply service Medigene presents at Annual Needham Healthcare Conference in NY
  Index term 2 Medigene–BioCentury: investor conference, 201704 supply service Medigene presents at Future Leaders in Biotech Industry in NY
Persons Person Taapken, Thomas (Medigene 201701– CFO before Epigenomics + Biotie/elbion + DVC + Burrill + Hoechst)
  Person 2 Schendel, Dolores J. (Medigene 201602– CEO before CMO before Trianta Immunotherapies + HelmholtzZentrum München)
     


Medigene AG (FWB: MDG1, Prime Standard, TecDAX) today announced its participation at six upcoming scientific and investor conferences:

* Metzler MicroCap Day
Date: March 29 - 30, 2017
Location: Frankfurt/Main, Germany

* American Association for Cancer Research - AACR Annual Meeting
Date: April 1 - 5, 2017
Location: Washington DC, USA
Dr. Manon Weis, scientist, gives an oral presentation on April 4th at 03.05 PM
on the topic: "Isolation and characterization of a PRAME-specific TCR with high avidity, potent antitumor efficacy and a favorable preclinical safety profile". An abstract is available under: ( www.abstractsonline.com/pp8/# !/4292/presentation/5970)

Furthermore, our cooperation partner from the Oslo University Hospital will present a poster on April 4th during 08.00 AM to 12.00 PM on the topic: "WT1 and PRAME mRNA transfected TLR 7/8-polarized fast DC vaccines in AML patients mount specific immune responses and impact progression free survival". An abstract is available under: ( www.abstractsonline.com/pp8/# !/4292/presentation/5996)

* 16th Annual Needham Healthcare Conference
Date: April 4 - 5, 2017
Location: New York, USA
Medigenes CFO, Dr. Thomas Taapken, will hold a company presentation on April 4th at 05.00 PM.

* 24th BioCentury Future Leaders in the Biotech Industry
Date: April 7, 2017
Location: New York, USA
Medigenes CFO, Dr. Thomas Taapken, will hold a company presentation at 10.30 AM.

* Molecular Diagnostics Europe
Date: April 10 - 13, 2017
Location: Lisbon, Portugal

* European Neoantigen Summit 2017
Date: April 24 -26, 2017
Location: Amsterdam, Netherlands
Prof. Dolores Schendel, Medigenes CEO / CSO, gives a presentation on April 26th at 01.45 PM on the topic: "Rapid High-Throughput Technologies Allow Functional Identification of Neoantigens for Vaccines and TCR-Based Immunotherapies".


Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard, TecDAX) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative immunotherapies to target various forms and stages of cancer. Medigene concentrates on the development of personalized T cell-based therapies, with associated projects currently in clinical and pre-clinical development.

For more information, please visit www.medigene.com


This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.

   
Record changed: 2017-07-02

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px